Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of Extended-Release Methylphenidate Treatment on Cognitive Task Performance in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.
Pearson DA, Santos CW, Aman MG, Arnold LE, Lane DM, Loveland KA, Mansour R, Ward AR, Casat CD, Jerger S, Schachar RJ, Bukstein OG, Cleveland LA. Pearson DA, et al. Among authors: aman mg. J Child Adolesc Psychopharmacol. 2020 Sep;30(7):414-426. doi: 10.1089/cap.2020.0004. Epub 2020 Jul 9. J Child Adolesc Psychopharmacol. 2020. PMID: 32644833 Free PMC article.
High concordance of parent and teacher attention-deficit/hyperactivity disorder ratings in medicated and unmedicated children with autism spectrum disorders.
Pearson DA, Aman MG, Arnold LE, Lane DM, Loveland KA, Santos CW, Casat CD, Mansour R, Jerger SW, Ezzell S, Factor P, Vanwoerden S, Ye E, Narain P, Cleveland LA. Pearson DA, et al. Among authors: aman mg. J Child Adolesc Psychopharmacol. 2012 Aug;22(4):284-91. doi: 10.1089/cap.2011.0067. Epub 2012 Jul 31. J Child Adolesc Psychopharmacol. 2012. PMID: 22849541 Free PMC article.
Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms.
Pearson DA, Santos CW, Aman MG, Arnold LE, Casat CD, Mansour R, Lane DM, Loveland KA, Bukstein OG, Jerger SW, Factor P, Vanwoerden S, Perez E, Cleveland LA. Pearson DA, et al. Among authors: aman mg. J Child Adolesc Psychopharmacol. 2013 Jun;23(5):337-51. doi: 10.1089/cap.2012.0096. J Child Adolesc Psychopharmacol. 2013. PMID: 23782128 Free PMC article. Clinical Trial.
Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorder.
Farmer CA, Brown NV, Gadow KD, Arnold LE, Kolko DG, Findling RL, Molina BS, Buchan-Page KA, Rice RR Jr, Bangalore SS, Bukstein O, Rundberg-Rivera EV, McNamara N, Aman MG. Farmer CA, et al. Among authors: aman mg. J Child Adolesc Psychopharmacol. 2015 Apr;25(3):213-24. doi: 10.1089/cap.2014.0109. J Child Adolesc Psychopharmacol. 2015. PMID: 25885011 Free PMC article. Clinical Trial.
Risperidone Added to Psychostimulant in Children with Severe Aggression and Attention-Deficit/Hyperactivity Disorder: Lack of Effect on Attention and Short-Term Memory.
Farmer CA, Epstein JN, Findling RL, Gadow KD, Arnold LE, Kipp H, Kolko DJ, Butter E, Schneider J, Bukstein OG, McNamara NK, Molina BS, Aman MG. Farmer CA, et al. Among authors: aman mg. J Child Adolesc Psychopharmacol. 2017 Mar;27(2):117-124. doi: 10.1089/cap.2016.0040. Epub 2016 Jun 27. J Child Adolesc Psychopharmacol. 2017. PMID: 27348211 Free PMC article. Clinical Trial.
Atomoxetine, Parent Training, and Their Effects on Sleep in Youth with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.
Hollway JA, Mendoza-Burcham M, Andridge R, Aman MG, Handen B, Arnold LE, Lecavalier L, Williams C, Silverman L, Smith T. Hollway JA, et al. Among authors: aman mg. J Child Adolesc Psychopharmacol. 2018 Mar;28(2):130-135. doi: 10.1089/cap.2017.0085. Epub 2017 Nov 7. J Child Adolesc Psychopharmacol. 2018. PMID: 29112459 Free PMC article. Clinical Trial.
Development of a Composite Primary Outcome Score for Children with Attention-Deficit/Hyperactivity Disorder and Emotional Dysregulation.
Johnstone JM, Leung BMY, Srikanth P, Hatsu I, Perez L, Gracious B, Tost G, Aman MG, Gadow KD, Findling RL, Bukstein O, Arnold LE. Johnstone JM, et al. Among authors: aman mg. J Child Adolesc Psychopharmacol. 2020 Apr;30(3):166-172. doi: 10.1089/cap.2019.0179. Epub 2020 Feb 26. J Child Adolesc Psychopharmacol. 2020. PMID: 32101469 Free PMC article.
Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.
Aman M, Rettiganti M, Nagaraja HN, Hollway JA, McCracken J, McDougle CJ, Tierney E, Scahill L, Arnold LE, Hellings J, Posey DJ, Swiezy NB, Ghuman J, Grados M, Shah B, Vitiello B. Aman M, et al. J Child Adolesc Psychopharmacol. 2015 Aug;25(6):482-93. doi: 10.1089/cap.2015.0005. J Child Adolesc Psychopharmacol. 2015. PMID: 26262903 Free PMC article. Clinical Trial.
257 results